Background and Aim: Neutrophil gelatinase-associated lipocalin (NGAL) is derived from the distal tubule and is both reabsorbed and filtered and also shed into the urine after tubular injury. Plasma NGAL is unique amongst the candidate biomarkers of acute kidney injury (AKI) since elevated concentrations may reflect either a change in renal glomerular function or in structural tubular injury or both. In this study, we compared the performance of plasma NGAL in the diagnosis of functional changes and in the diagnosis of structural injury. Methods: Plasma and urine samples from 528 patients were collected on entry to an intensive care unit (ICU) as well as 12 and 24 h later. Plasma NGAL diagnostic performance was independently assessed for Functional-AKI and Structural-AKI. Functional-AKI was defined by changes in plasma creatinine, whereas Structural-AKI was defined by elevations in urinary NGAL. Results: On ICU entry, the area under the curve (AUC) for the diagnosis of Functional-AKI was 0.74 (95% CI: 0.69-0.79), and for Structural-AKI it was 0.79 (0.74-0.83). Plasma NGAL also predicted the need for dialysis (0.79; 0.66-0.81), but not for death. A principal component analysis demonstrated that the maximum plasma NGAL in 24 h reflected structural injury marginally more than functional changes. Plasma NGAL added value to an AKI diagnostic model comprising plasma creatinine, sepsis, age, and APACHE II score (integrated discrimination improvement: 0.073; 0.034-0.12). Conclusion: Increased plasma NGAL reflects both decreased filtration and structural injury. For patients at a low calculated risk, the addition of NGAL reduced the risk, and for those at a higher risk, NGAL correctly assigned patients to even a higher risk.

1.
Cruz DN, Bagshaw SM, Ronco C, Ricci Z: Acute kidney injury: classification and staging. Contrib Nephrol 2010;164:24-32.
2.
Nejat M, Pickering JW, Walker RJ, Endre ZH: Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010;25:3283-3289.
3.
Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, et al: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-1122.
4.
Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, et al: The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011;57:1752-1761.
5.
Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N: The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 2005;579:773-777.
6.
Nejat M, Hill JV, Pickering JW, Edelstein CL, Devarajan P, Endre ZH: Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant 2012;27:iii96-iii103.
7.
de Geus HR, Bakker J, Lesaffre EM, le Noble JL: Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011;183:907-914.
8.
Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, et al: The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010;56:52-59.e1.
9.
Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, et al: Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010;36:444-451.
10.
Constantin JM, Futier E, Perbet S, Roszyk L, Lautrette A, Gillart T, et al: Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 2010;25:176.e1-e6.
11.
Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, et al: Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011;22:1748-1757.
12.
Endre ZH, Kellum JA, Di Somma S, Doi K, Goldstein SL, Koyner JL, et al: Differential Diagnosis of AKI in Clinical Practice by Functional and Damage Biomarkers: Workgroup Statements from the Tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013;182:30-44.
13.
Endre ZH, Pickering JW: Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI). Nephrol Dial Transplant 2010;25:107-118.
14.
Endre ZH, Pickering JW, Walker RJ, Devarajan P, Edelstein CL, Bonventre JV, et al: Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011;79:1119-1130.
15.
KDIGO: Clinical Practice Guideline for Acute Kidney Injury. Section 2: AKI Definition. Kidney Int Suppl 2012;2:19-36.
16.
Pickering JW, Endre ZH: Linking injury to outcome in acute kidney injury: a matter of sensitivity. PLoS ONE 2013;8:e62691.
17.
Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
18.
McIlroy DR, Wagener G, Lee HT: Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010;5:211-219.
19.
DeLong E, DeLong D, Clarke-Pearson D: Comparing the areas under 2 or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
20.
Pencina MJ, D'Agostino RB, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172.
21.
Pickering JW, Endre ZH: New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol 2012;7:1355-1364.
22.
Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, et al: Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010;36:452-461.
23.
Martensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR: Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010;36:1333-1340.
24.
Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, et al: Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010;14:R9.
25.
Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, et al: Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008;36:1297-1303.
26.
Kokkoris S, Parisi M, Ioannidou S, Douka E, Pipili C, Kyprianou T, et al: Combination of renal biomarkers predicts acute kidney injury in critically ill adults. Ren Fail 2012;34:1100-1108.
27.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
28.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky PM, Acute Dialysis Quality Initiative workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
29.
Lentini P, de Cal M, Clementi A, D'Angelo A, Ronco C: Sepsis and AKI in ICU patients: the role of plasma biomarkers. Crit Care Res Pract 2012;2012:856401.
30.
Bellomo R, Bagshaw SM, Langenberg C, Ronco C: Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol 2007;156:1-9.
31.
Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein CL, Walker RJ, et al: Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012;81:1254-1262.
32.
Lisowska-Myjak B: Serum and urinary biomarkers of acute kidney injury. Blood Purif 2010;29:357-365.
33.
Moriates C, Maisel A: The utility of biomarkers in sorting out the complex patient. Am J Med 2010;123:393-399.
34.
McCullough PA, Shaw AD, Haase M, Bouchard J, Waikar SS, Siew ED, et al: Implementation of Novel Biomarkers in the Diagnosis, Prognosis, and Management of Acute Kidney Injury: Executive Summary from the Tenth consensus Conference of the Acute Dialysis Quality Initiative. Contrib Nephrol 2013;182:5-12.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.